Completed PHASE3 INTERVENTIONAL 3-arm NCT00043550

Treatments for Depression: Drug Versus Psychotherapy

Efficacy of Dynamic Therapy Versus Selective Serotonin Reuptake Inhibitor for Depression

Sponsor: National Institute of Mental Health (NIMH)

Interventions Pill Placebo Sertraline Supportive Expressive Therapy Venlafaxine

Updated 8 times since 2017 Last updated: Apr 28, 2017 Started: Nov 30, 2001 Primary completion: Jun 30, 2009 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00043550, this PHASE3 trial focuses on Depression and remains completed. Sponsored by National Institute of Mental Health (NIMH), it has been updated 8 times since 2001, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Dec 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Dec 2021 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jul 2017 — Jun 2018 [monthly]

Completed PHASE3
Feb 2017 — Jul 2017 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Nov 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Mental Health (NIMH)
University of Pennsylvania

Data source: University of Pennsylvania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States